Selected article for: "entry receptor and therapeutic development"
Author: Israelow, Benjamin; Song, Eric; Mao, Tianyang; Lu, Peiwen; Meir, Amit; Liu, Feimei; Alfajaro, Mia Madel; Wei, Jin; Dong, Huiping; Homer, Robert J.; Ring, Aaron; Wilen, Craig B.; Iwasaki, Akiko
Title: Mouse model of SARS-CoV-2 reveals inflammatory role of type I interferon signaling
  • Cord-id: fk1x36fd
  • Document date: 2020_8_4
    • ID: fk1x36fd
    Snippet: Severe acute respiratory syndrome–coronavirus 2 (SARS-Cov-2) has caused over 13,000,000 cases of coronavirus disease (COVID-19) with a significant fatality rate. Laboratory mice have been the stalwart of therapeutic and vaccine development; however, they do not support infection by SARS-CoV-2 due to the virus’s inability to use the mouse orthologue of its human entry receptor angiotensin-converting enzyme 2 (hACE2). While hACE2 transgenic mice support infection and pathogenesis, these mice a
    Document: Severe acute respiratory syndrome–coronavirus 2 (SARS-Cov-2) has caused over 13,000,000 cases of coronavirus disease (COVID-19) with a significant fatality rate. Laboratory mice have been the stalwart of therapeutic and vaccine development; however, they do not support infection by SARS-CoV-2 due to the virus’s inability to use the mouse orthologue of its human entry receptor angiotensin-converting enzyme 2 (hACE2). While hACE2 transgenic mice support infection and pathogenesis, these mice are currently limited in availability and are restricted to a single genetic background. Here we report the development of a mouse model of SARS-CoV-2 based on adeno-associated virus (AAV)–mediated expression of hACE2. These mice support viral replication and exhibit pathological findings found in COVID-19 patients. Moreover, we show that type I interferons do not control SARS-CoV-2 replication in vivo but are significant drivers of pathological responses. Thus, the AAV-hACE2 mouse model enables rapid deployment for in-depth analysis following robust SARS-CoV-2 infection with authentic patient-derived virus in mice of diverse genetic backgrounds.

    Search related documents:
    Co phrase search for related documents
    • activation immune cell recruitment and acute respiratory syndrome sars cov coronavirus: 1, 2, 3
    • activation immune cell recruitment and adaptive immunity: 1
    • activation immune cell recruitment and adaptive innate: 1
    • activation recruitment and acute inflammatory response: 1
    • activation recruitment and acute respiratory syndrome sars cov coronavirus: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10
    • activation recruitment and adaptive immunity: 1, 2, 3, 4, 5
    • activation recruitment and adaptive immunity role: 1
    • activation recruitment and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14
    • acute inflammatory response and adaptive innate: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome sars cov coronavirus and adaptive immunity: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome sars cov coronavirus and adaptive immunity role: 1, 2, 3, 4, 5, 6
    • acute respiratory syndrome sars cov coronavirus and adaptive innate: 1, 2, 3, 4, 5, 6, 7, 8, 9, 10, 11, 12, 13, 14, 15, 16, 17, 18, 19, 20, 21, 22, 23, 24, 25
    • acute respiratory syndrome sars cov coronavirus and adenoviral vector: 1, 2, 3, 4, 5, 6, 7, 8
    • adaptive immunity and adenoviral vector: 1
    • adaptive innate and adenoviral vector: 1